Skip to main content
OpenTrials
Completed

NCT Number: NCT01808209

Clinical Performance of Stenfilcon A Versus Filcon II 3

Clinical Performance of Stenfilcon vs. Filcon II 3

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Aston

Birmingham, West Midlands, B4 7ET, United Kingdom

About this study

The objective of this study is to compare the comfort and clinical performance of Stenfilcon vs. Filcon II 3 compared to subject's habitual contact lenses. The null hypothesis is that there is no difference in the clinical performance between the two sets of lenses.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects must satisfy the following conditions prior to inclusion in the study:

  • Based on his/her knowledge, must be in good general health. Be of legal age (18 years) or older.
  • Be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluation.
  • Read, indicate understanding of, and sign Written Informed Consent (Appendix 1)
  • Require a contact lens prescription between -0.50 and -6.00 and have no more than -.75dioptor (D) of astigmatism in both eyes
  • Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens prescription.
  • An existing soft contact lens wearer of any modality.
  • Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so.
  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
  • No amblyopia.
  • No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes).
  • No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival injection).
  • No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology.)
  • No aphakia

Exclusion criteria

Any of the following will render a subject ineligible for inclusion:

  • Neophytes, who have not worn lenses before
  • Greater than 0.75D of refractive astigmatism in either eye
  • Presence of clinically significant (grade 3 or above) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • Presence of ocular or systemic disease or need of medication which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from the limbus
  • Giant papillary conjunctivitis (GPC) Grade 3 or above
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, seborrheic conjunctivitis
  • History of corneal ulcer or fungal infections
  • Poor personal hygiene
  • A known history of corneal hypoesthesia (reduced corneal sensitivity).
  • Contact lens best corrected Snellen visual acuities (VA) worse than 6/9
  • Aphakia, Keratoconus or a highly irregular cornea

Treatment and study plan

stenfilcon A

Device

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Other names: stenfilcon A (Daily Disposable Contact Lens)

filcon II 3

Device

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Other names: filcon II 3 (Daily Disposable Contact Lens)

Primary outcomes

  1. Daily and Comfortable Wearing Time

    Time frame: Baseline

    Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)

  2. Daily and Comfortable Wearing Time

    Time frame: 1 week

    Participant rating of lens Daily and Comfortable Wearing Time. Collected at 1 week wear for each lens.(The hours of average comfortable wearing time and average daily wearing time.)

  3. Handling

    Time frame: 1 Week

    Participant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).

  4. Comfort

    Time frame: Baseline

    Participant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)

  5. Comfort

    Time frame: 1 Week

    Participant rating for comfort. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

  6. Dryness

    Time frame: Baseline

    Participant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)

  7. Dryness

    Time frame: 1 Week

    Participant rating for dryness. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).

  8. Vision Quality

    Time frame: Baseline

    Participant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

  9. Vision Quality

    Time frame: 1 Week

    Participant rating of vision quality. Collected at 1 week. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)

  10. Eye Whiteness

    Time frame: Baseline

    Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

  11. Eye Whiteness

    Time frame: 1 Week

    Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).

  12. Overall Satisfaction

    Time frame: Baseline

    Participant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

  13. Overall Satisfaction

    Time frame: 1 Week

    Participant rating for overall satisfaction. Collected at 1 week for study lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).

  14. Visual Acuity logMAR

    Time frame: Baseline

    Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.

  15. Visual Acuity logMAR

    Time frame: Dispense

    Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at dispense for study lenses. logMAR.

  16. Visual Acuity logMAR

    Time frame: 1 Week

    Assessment of Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at 1 week for study lenses. logMAR

  17. Wettability

    Time frame: 1 Week

    Participant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.

Secondary outcomes

  1. Blood Vessel Coverage

    Time frame: Baseline

    Assessment of ocular health. Collected at baseline after removal of lenses. Percent of blood vessel coverage.

  2. Blood Vessel Coverage

    Time frame: 1 Week

    Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of blood vessel coverage.

  3. Conjunctival Redness

    Time frame: Baseline

    Assessment of ocular health. Collected at baseline after removal of lenses. Percentage of conjunctival redness.

  4. Conjunctival Redness

    Time frame: 1 Week

    Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of conjunctival redness.

  5. Corneal Staining

    Time frame: Baseline

    Assessment of ocular health. Collected at baseline after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

  6. Corneal Staining

    Time frame: 1 Week

    Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

  7. Conjunctival Staining

    Time frame: 1 Week

    Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Mar 11, 2013
Registry last updated
Aug 3, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.